中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/30300
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 29490/55136 (53%)
造访人次 : 1910323      在线人数 : 173
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于CMUR管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/30300


    题名: REGIOSELECTIVITY ENHANCEMENT BY PARTIAL-PURIFICATION OF LIPASE FROM ASPERGILLUS-NIGER
    作者: CHEN, HP;HSIAO, KF;WU, SH;WANG, KT
    贡献者: 醫學院醫學系生化學科;ACAD SINICA,INST BIOL CHEM,TAIPEI,TAIWAN;CHINA MED COLL,DEPT BIOCHEM,TAICHUNG,TAIWAN;NATL TAIWAN UNIV,DEPT CHEM,TAIPEI 10764,TAIWAN
    日期: 1995
    上传时间: 2010-09-24 14:52:49 (UTC+8)
    出版者: CHAPMAN HALL LTD
    摘要: An indazole derivative, YC-1, was identified in this study to be capable of reversibly and effectively inhibiting proliferation of rat A10 vascular smooth-muscle cells (VSMCs) in vitro. YC-1 (1-100 mu M) dose-dependently inhibited [H-3]thymidine incorporation into DNA in rat A10 VSMCs that were synchronized by serum depletion and then restimulated by addition of 10% foetal calf serum (FCS), whereas FCS-induced [H-3]thymidine incorporation into rat synchronized endothelial cells was unaffected by this agent. The dose of YC-1 required to cause inhibition of FCS-induced proliferation was similar to that necessary for the formation of cellular cyclic GMP (cGMP). Guanylate cyclase activity in soluble fractions of VSMCs was activated by YC-1 (1-100 mu M), whereas cGMP-specific phosphodiesterase activity was unaffected by this compound. The anti-proliferative effect of YC-1 was mimicked by 8-bromo-cGMP, a membrane-permeable cGMP analogue, and was antagonized by KT 5823 (0.2 mu M), a selective inhibitor of protein kinase G. The anti-proliferative effect of YC-1 was also antagonized by Methylene Blue (50 mu M), a guanylate cyclase inhibitor, and was potentiated by 3-isobutyl-1-methylxanthine (500 mu M), a phosphodiesterase inhibitor. These results verified that YC-1 is a direct soluble guanylate cyclase activator in A10 VSMCs, and the anti-proliferative effect of YC-1 is mediated by cGMP. YC-1 still inhibited FCS-induced DNA synthesis even when added 10-18 h after restimulation of the serum-deprived A10 VSMCs with 10% FCS. Flow cytometry in synchronized populations revealed an acute blockage of FCS-inducible cell-cycle progression at a point in the G(1)/S-phase in YC-1 (100 mu M)-treated cells. The inhibition of proliferation by YC-1 was demonstrated to be independent of cell damage, as documented by several criteria of cell viability. In conclusion, YC-1 reversibly and effectively inhibited the proliferation of VSMCs,suggesting that it has potential as a therapeutic agent in the prevention of vascular diseases.
    關聯: BIOTECHNOLOGY LETTERS 17(3):305-308
    显示于类别:[醫學系] 期刊論文

    文件中的档案:

    没有与此文件相关的档案.



    在CMUR中所有的数据项都受到原著作权保护.

    TAIR相关文章

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈